Physician
Anesthesiology
Dr. Lynn R. Webster, MD
|
|
Give Review
Lynn Webster practices Anesthesiology. He researched medicine at University of Nebraska College of Medicine. He over the years received 1 awards: "Top MD". Lynn Webster is also a published MD. He has 85 publication published. The most recent publication is: Information needs of cancer patients in west Scotland: cross sectional survey of patients'' views.
Publications
- Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trials.
- Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation.
- Current Regulations Related to Opioid Prescribing.
- Medical management of chronic low back pain: efficacy and outcomes.
- Comparative Effects of Morning vs Evening Dosing of Extended-Release Hydromorphone on Sleep Physiology in Patients with Low Back Pain: A Pilot Study.
- Pain and Suicide: The Other Side of the Opioid Story.
- New policing role for pharmacists undermines partnership with prescribers.
- Why We Need Narratives of Healing and Qualitative Pain Research.
- Pills, Polices, and Predicaments: The Unintended Consequences of a Health Care System's Policy toward Opioids.
- Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the United States: a report on initial efforts.
- Intrathecal gabapentin to treat chronic intractable noncancer pain.
- Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Cancer and Noncancer ...
- Eight principles for safer opioid prescribing.
- A responsible way to treat patients and pain.
- Risk factors for drug diversion in a pain clinic patient population.
- Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.
- Overdose deaths demand a new paradigm for opioid rotation.
- Review and critique of opioid rotation practices and associated risks of toxicity.
- Efficacy and safety of dual-opioid therapy in acute pain.
- Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain.
- Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain.
- Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia.
- 6?-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study.
- Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting.
- Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsules.
- Impact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced, nondependent male opioid users.
- Our academy, our mission, our work!
- NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic Neur...
- Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain.
- Letter to the editor in response to "The evidence for pharmacological treatment of neuropathic pain," by Finnerup et al.
- An analysis of the root causes for opioid-related overdose deaths in the United States.
- Obtaining adequate data to determine causes of opioid-related overdose deaths.
- A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose.
- System dynamics modeling as a potentially useful tool in analyzing mitigation strategies to reduce overdose deaths associated with pharmaceutical opioid treatment of c...
- Ending unnecessary opioid-related deaths: a national priority.
- Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
- Comprehensive Consensus Based Guidelines on Intrathecal Drug Delivery Systems in the Treatment of Pain Caused by Cancer Pain.
- Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain.
- Long-term safety of Remoxy® (extended-release oxycodone) in patients with moderate to severe chronic osteoarthritis or low back pain.
- Efficacy and safety of an extended-release oxycodone (Remoxy) formulation in patients with moderate to severe osteoarthritic pain.
- Use of an algorithm applied to urine drug screening to assess adherence to a hydrocodone regimen.
- The abuse potential of Remoxy(®), an extended-release formulation of oxycodone, compared with immediate- and extended-release oxycodone.
- An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics.
- A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain.
- Long-term safety and efficacy of morphine sulfate and naltrexone hydrochloride extended release capsules, a novel formulation containing morphine and sequestered naltr...
- Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the t...
- A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
- Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base.
- Approaches to improve pain relief while minimizing opioid abuse liability.
- Considering the risks of benzodiazepines and opioids together.
- Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
- Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need.
- Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery.
- Use of an algorithm applied to urine drug screening to assess adherence to an oxycontin regimen.
- Intrathecal ziconotide for complex regional pain syndrome: seven case reports.
- Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
- Unintended harm from opioid prescribing guidelines.
- Long-term intrathecal ziconotide for chronic pain: an open-label study.
- Opioid formulations in development designed to curtail abuse: who is the target?
- Hypoxemia in patients on chronic opiate therapy with and without sleep apnea.
- Pharmacogenetics in pain management: the clinical need.
- Pain and addiction interface.
- Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind,...
- Sleep-disordered breathing and chronic opioid therapy.
- Breakthrough pain in the management of chronic persistent pain syndromes.
- Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
- Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation.
- Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl ci...
- PTI-821: sustained-release oxycodone using gel-cap technology.
- Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
- Fentanyl buccal tablets.
- Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain.
- A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.
- Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool.
- Methadone-related deaths.
- A consensus statement regarding the present suggested titration for prialt (ziconotide).
- Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain.
- Modafinil treatment of opioid-induced sedation.
- A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer.
- Burnout and leadership in community mental health systems.
- Information needs of cancer patients in west Scotland: cross sectional survey of patients'' views.
- Detection of BRCA1 mutations by the protein truncation test.
- Opioid analgesics: Does potency matter?
- Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
Schools
University of Nebraska College of Medicine
University Of Ut Med Center
Doctors Specialties
- Anesthesiology
- Pain Medicine Anesthesiology
Accepted Insurances
Awards
- Top MD
Education
-
University of Utah -
University of Nebraska College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Norman J. Clark, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Issaku Ueda, MD |
|
|
Dr. M Ericksen, MD |
|
|
Dr. Steven I. Bott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffery D. Porth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip N. Gnadinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Odell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan L. Pace, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Benjamin S. Gmelch, MD |
|
|
Dr. Tyler R. Call, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Skaggs, MD
This Doctor is OpenDoctor Recommended.
|